Get access
Clinical & Experimental Allergy

Changing practice: no need to stop ACE inhibition for venom immunotherapy

Authors

  • C. A. Slade,

    1. Department of Clinical Immunology and Allergy, Royal Melbourne Hospital, Parkville, Vic., Australia
    2. Department of Medicine, University of Melbourne, Parkville, Vic., Australia
    3. Walter and Eliza Hall Research Institute, Parkville, Vic., Australia
    Search for more papers by this author
  • J. A. Douglass

    1. Department of Clinical Immunology and Allergy, Royal Melbourne Hospital, Parkville, Vic., Australia
    2. Department of Medicine, University of Melbourne, Parkville, Vic., Australia
    Search for more papers by this author

  • This editorial discusses the findings of the papers in this issue by J. Stoevesandt et al. [6] pp. 747–755 and F. Rueff et al. [7] pp. 736–746

Correspondence: Professor Jo Douglass

Department of Clinical Immunology and Allergy

Royal Melbourne Hospital, Grattan St, Parkville, Vic.

Australia. E-mail: jo.douglass@mh.org.au

No abstract is available for this article.

Get access to the full text of this article

Ancillary